NCT00981656 Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer Status COMPLETED Phase PHASE2
NCT00971932 Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) Status COMPLETED Phase PHASE2
NCT00950300 A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer Status COMPLETED Phase PHASE3
NCT00943137 The Optimization of 5-Fluorouracil Dose by Pharmacokinetic Monitoring in Asian Patients With Advanced Stage Cancer Status UNKNOWN Phase PHASE2
NCT00941655 Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial Status COMPLETED Phase PHASE3
NCT00932438 Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab Status COMPLETED Phase PHASE1/PHASE2
NCT00889343 Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00865189 A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT00849615 Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction Status COMPLETED Phase PHASE2
NCT00847912 CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial Status COMPLETED Phase PHASE4
NCT00811447 Taxotere New Indication - Gastric Cancer Treatment Registration Trial Status COMPLETED Phase PHASE3
NCT00786643 Study of Gamma Interfereon in Metastatic Colorectal Carcinoma Status COMPLETED Phase PHASE2
NCT00782041 Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer Status TERMINATED Phase PHASE2
NCT00755118 Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc Status TERMINATED Phase PHASE2
NCT00737373 Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer Status COMPLETED Phase PHASE2
NCT00689624 Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00625898 BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab Status TERMINATED Phase PHASE3
NCT00611858 Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Status TERMINATED Phase PHASE2
NCT00602745 S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen Status TERMINATED Phase PHASE3